WITHDRAWAL SYMPTOMS AFTER ABRUPT CESSATION OF ANTIPSYCHOTIC COMPOUNDS: CLINICAL CONFIRMATION IN CHRONIC SCHIZOPHRENICS.
D014150:Antipsychotic Agents; D035843:Biomedical Research; D010634:Phenobarbital; D010640:Phenothiazines; D010919:Placebos; D012559:Schizophrenia; D013375:Substance Withdrawal Syndrome; D014116:Toxicology; D014149:Tranquilizing Agents; D014268:Trifluoperazine
D014150:Antipsychotic Agents; D010640:Phenothiazines; D010919:Placebos; D014149:Tranquilizing Agents; D014268:Trifluoperazine; C084595:butaperazine; D010634:Phenobarbital
BUTAPERAZINE; CLINICAL RESEARCH; DRUG WITHDRAWAL SYMPTOMS; PHENOBARBITAL; PLACEBOS; SCHIZOPHRENIA; TOXICOLOGIC REPORT; TRANQUILIZING AGENTS; TRIFLUOPERAZINE